Skip to main content
FasterCures developing tools for the science of patient input

HIV/AIDS community activism not only pushed the FDA, NIH, Congress and drugmakers to devote resources to the deadly disease, it also opened a new front in drug development: the science of patient input. FasterCures is among the groups developing tools that industry and nonprofit organizations can use to learn about patients' experiences and priorities, and incorporate those data into drug development. "We're learning how we can get insights from patients earlier in the development process," FasterCures Executive Director Margaret Anderson said.

Full Story: